89 related articles for article (PubMed ID: 1582985)
1. Cellular and molecular genetic features of myeloma and related disorders.
Durie BG
Hematol Oncol Clin North Am; 1992 Apr; 6(2):463-77. PubMed ID: 1582985
[TBL] [Abstract][Full Text] [Related]
2. Chromosomes in plasma-cell malignancies.
Van Den Berghe H
Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
[TBL] [Abstract][Full Text] [Related]
3. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular genetic changes in malignant transformation of immortalized esophageal epithelial cells.
Shen ZY; Xu LY; Chen MH; Cai WJ; Shen J; Chen JY; Zeng Y
Int J Mol Med; 2003 Aug; 12(2):219-24. PubMed ID: 12851721
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of multiple myeloma.
Tonon G
Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585
[TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of multiple myeloma cells].
Yasuga Y; Hirosawa S
Nihon Rinsho; 1995 Mar; 53(3):564-7. PubMed ID: 7699886
[TBL] [Abstract][Full Text] [Related]
7. Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells.
Endo K; Borer CH; Tsujimoto Y
Oncogene; 1991 Aug; 6(8):1391-6. PubMed ID: 1653411
[TBL] [Abstract][Full Text] [Related]
8. Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma.
Intini D; Agnelli L; Ciceri G; Ronchetti D; Fabris S; Nobili L; Lambertenghi-Deliliers G; Lombardi L; Neri A
Hematol Oncol; 2007 Mar; 25(1):6-10. PubMed ID: 17036375
[TBL] [Abstract][Full Text] [Related]
9. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics and molecular cytogenetics in multiple myeloma.
Liebisch P; Döhner H
Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biology of cell death].
Tsujimoto Y
Gan To Kagaku Ryoho; 1994 Apr; 21(5):591-5. PubMed ID: 8154883
[TBL] [Abstract][Full Text] [Related]
13. Genetics of multiple myeloma.
Higgins MJ; Fonseca R
Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
[TBL] [Abstract][Full Text] [Related]
14. ras mutations in human leukemia and related disorders.
Greenberger JS
Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
[TBL] [Abstract][Full Text] [Related]
15. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
[TBL] [Abstract][Full Text] [Related]
16. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
Lombardi L; Poretti G; Mattioli M; Fabris S; Agnelli L; Bicciato S; Kwee I; Rinaldi A; Ronchetti D; Verdelli D; Lambertenghi-Deliliers G; Bertoni F; Neri A
Genes Chromosomes Cancer; 2007 Mar; 46(3):226-38. PubMed ID: 17171682
[TBL] [Abstract][Full Text] [Related]
18. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
19. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Gaidano G; Pastore C; Volpe G
Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]